Fluticasone Nasal
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
An intranasal corticosteroid (INCS) considered the most effective pharmacotherapy class for allergic rhinitis. Fluticasone propionate (Flonase) and fluticasone furoate (Veramyst/Flonase Sensimist) reduce nasal inflammation, congestion, rhinorrhea, sneezing, and itching. Recommended as first-line therapy for moderate-to-severe allergic rhinitis by all major guidelines. Available over-the-counter (Flonase). Also effective for non-allergic rhinitis and nasal polyps.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
An intranasal corticosteroid (INCS) considered the most effective pharmacotherapy class for allergic rhinitis. NutriStack rates the supporting evidence as strong. Common adult dosing is Adults: 1-2 sprays (50 mcg each) per nostril once daily; children >=4 years: 1 spray per nostril once daily; Sensimist: 1-2 sprays (27.5 mcg each) per nostril once daily (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: most effective single-agent therapy for allergic rhinitis, relieves nasal congestion (superior to oral antihistamines for this symptom), reduces sneezing, rhinorrhea, and nasal itching. 10 sources indexed (1998–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to intracellular glucocorticoid receptors in nasal mucosal cells. The activated complex translocates to the nucleus and modulates transcription of inflammatory genes, suppressing cytokines (IL-1, IL-4, IL-5, IL-13), chemokines, adhesion molecules (ICAM-1, VCAM-1), and inflammatory enzymes. Reduces eosinophil, mast cell, T-lymphocyte, and basophil infiltration in the nasal mucosa. Decreases vascular permeability and mucus gland secretion. Minimal systemic absorption (<2% bioavailability for fluticasone propionate).1,2
Dosing & protocol.
Applied intranasally. Systemic bioavailability extremely low (<2% for fluticasone propionate; 0.5% for fluticasone furoate). Shake well before use. Aim spray away from nasal septum. Prime before first use. Regular daily use is needed for maximum benefit, not for as-needed symptom relief.
Full safety detail.
Side effects
- Epistaxis (nosebleed), most common
- Nasal dryness or irritation
- Headache
- Pharyngitis
- Unpleasant taste or smell
- Nasal septal perforation (rare, with improper technique)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
1- 1Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysisPMIDBielory L, Gross GN, Letierce A et al. · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2020
Bielory L, Gross GN, Letierce A et al.. Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2020
Randomized controlled trials
3- 2Nasal saline irrigation with azelastine-fluticasone nasal spray in moderate-to-severe persistent allergic rhinitis: a randomized controlled trialPMIDLi S, Xu R, Yu S et al. · Frontiers in allergy · 2025
Li S, Xu R, Yu S et al.. Nasal saline irrigation with azelastine-fluticasone nasal spray in moderate-to-severe persistent allergic rhinitis: a randomized controlled trial. Frontiers in allergy. 2025
- 3Intranasal fluticasone furoate in pediatric allergic rhinitis: randomized controlled studyPMIDZhang Y, Wei P, Chen B et al. · Pediatric research · 2021
Zhang Y, Wei P, Chen B et al.. Intranasal fluticasone furoate in pediatric allergic rhinitis: randomized controlled study. Pediatric research. 2021
- 4A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy studyPMIDHolm AF, Fokkens WJ, Godthelp T et al. · Clinical otolaryngology and allied sciences · 1998
Holm AF, Fokkens WJ, Godthelp T et al.. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clinical otolaryngology and allied sciences. 1998
Observational studies
1- 5Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two ContinentsPMIDDavis KJ, Hinds D, Motsko SP et al. · Drugs - real world outcomes · 2016
Davis KJ, Hinds D, Motsko SP et al.. Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents. Drugs - real world outcomes. 2016
Reference material
5- 6Brozek JL et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines, 2016 revision. J Allergy Clin Immunol. 2017.Source linkedPMID
- 7Weiner JM et al. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998.Source linkedPMID
- 8Dykewicz MS et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017.Source linkedPMID
- 9Tagaya E, Shinada J, Nagase H et al.. The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) study. The Journal of asthma : official journal of the Association for the Care of Asthma. 2025Source linkedPMID
- 10Ismaila AS, Haeussler K, Czira A et al.. Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in therapy. 2022Source linkedPMID
Common questions.
Quick answers about Fluticasone Nasal, drawn from the data on this page.
What is Fluticasone Nasal?
An intranasal corticosteroid (INCS) considered the most effective pharmacotherapy class for allergic rhinitis. Fluticasone propionate (Flonase) and fluticasone furoate (Veramyst/Flonase Sensimist) reduce nasal inflammation, congestion, rhinorrhea, sneezing, and itching. Recommended as first-line therapy for moderate-to-severe allergic rhinitis by all major guidelines. Available over-the-counter (Flonase). Also effective for non-allergic rhinitis and nasal polyps.
What is Fluticasone Nasal used for?
Commonly cited benefits of Fluticasone Nasal include: Most effective single-agent therapy for allergic rhinitis; Relieves nasal congestion (superior to oral antihistamines for this symptom); Reduces sneezing, rhinorrhea, and nasal itching; Effective for seasonal and perennial allergic rhinitis; Treats non-allergic rhinitis and nasal polyps. NutriStack rates the overall evidence as strong.
What is a typical dose of Fluticasone Nasal?
A typical adult dose of Fluticasone Nasal is Adults: 1-2 sprays (50 mcg each) per nostril once daily; children >=4 years: 1 spray per nostril once daily; Sensimist: 1-2 sprays (27.5 mcg each) per nostril once daily (as prescribed by your physician). The commonly recommended form is Nasal spray (aqueous suspension). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Fluticasone Nasal?
Reported side effects include epistaxis (nosebleed), most common, nasal dryness or irritation, headache, pharyngitis, unpleasant taste or smell, nasal septal perforation (rare, with improper technique). This is educational information; check with a healthcare professional before use.
How strong is the evidence for Fluticasone Nasal?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Fluticasone Nasal in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.